The identification of the CXCL16high B cell population in CVID led us to investigate their in vitro responses to CpG stimulation and compare them with those from healthy controls and CVID patients with low CXCL16 expression (Figures 6(a) and 6(b)). This evidence concerns the gene CXCL16 and common variable immunodeficiency.